Correlation Between Phathom Pharmaceuticals and Replimune
Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phathom Pharmaceuticals and Replimune Group, you can compare the effects of market volatilities on Phathom Pharmaceuticals and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and Replimune.
Diversification Opportunities for Phathom Pharmaceuticals and Replimune
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Phathom and Replimune is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and Replimune go up and down completely randomly.
Pair Corralation between Phathom Pharmaceuticals and Replimune
Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to under-perform the Replimune. In addition to that, Phathom Pharmaceuticals is 1.02 times more volatile than Replimune Group. It trades about -0.15 of its total potential returns per unit of risk. Replimune Group is currently generating about 0.09 per unit of volatility. If you would invest 1,037 in Replimune Group on September 6, 2024 and sell it today you would earn a total of 280.00 from holding Replimune Group or generate 27.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Phathom Pharmaceuticals vs. Replimune Group
Performance |
Timeline |
Phathom Pharmaceuticals |
Replimune Group |
Phathom Pharmaceuticals and Replimune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Phathom Pharmaceuticals and Replimune
The main advantage of trading using opposite Phathom Pharmaceuticals and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.The idea behind Phathom Pharmaceuticals and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |